Chemistry of Heterocyclic Compounds 2016, 52(9), 694–699
1
127.2, 125.6, 123.9, 120.1 (С Ar); 20.7 (CH3). Found, %:
C 53.98; H 4.35. C8H7N3O2. Calculated, %: C 54.24;
H 3.98.
(30%). Yellow crystals. Mp 90–91°C (decomp.). H NMR
spectrum, δ, ppm (J, Hz): 8.29–8.25 (1H, m, H Ar); 7.76–
7.70 (1H, m, J = 4.0, H Ar); 7.63–7.55 (2H, m, H Ar); 7.52–
7.44 (1H, m, H azepine); 6.64–6.58 (1H, m, H azepine);
6.36–6.30 (1H, m, H azepine); 3.89 (1H, s, H azepine);
3.83 (3H, s, OCH3). 13C NMR spectrum, δ, ppm: 167.5
(O–C=O); 160.6 (N–C=O); 150.9 (C–C=N); 136.9 (C=C-N);
135.2, 133.6, 127.9, 127.7, 127.5, 127.0, 122.2, 120.0,
118.5 (С azepine); 53.2 (C azepine); 51.9 (CH3). Mass
spectrum, m/z (Irel, %): 348 [M(81Br)]+ (15), 346 [M(79Br)]+
(16), 317 (17), 316 [M(81Br)–CH3OH]+ (96), 315 (22), 314
[M(79Br)–CH3OH]+ (100), 289 [M(81Br)–CH3OC(O)]+
(61), 288 (17), 287 [M(79Br)–CH3OC(O)]+ (62), 267 (37),
210 (21), 209 (53), 208 (30), 179 (28), 153 (16). Found, %:
C 51.87; H 3.24. C15H11BrN2O3. Calculated, %: C 51.90;
H 3.19.
2-Azido-5-bromobenzoic acid (1i) was obtained
analogously to a published method.11 Yield 78%. Colorless
needles. Mp 140°C (decomp.) IR spectrum (oil suspension),
ν, cm–1: 2144, 2119, 2085 (νas N3), 1697 (ν C=O), 1301 (νs
1
N3). H NMR spectrum, δ, ppm (J, Hz): 8.21 (1H, d,
J = 2.4, H Ar); 7.70 (1H, dd, J = 8.6, J = 2.4, H Ar); 7.16
(1H, d, J = 8.6, H Ar). 13C NMR spectrum, δ, ppm: 167.2
(C=O); 137.3, 136.0, 122.3, 121.4, 117.9 (С Ar). Found,
%: C 34.78; H 1.87. C7H4BrN3O2. Calculated, %: C 34.74;
H 1.67.
2-Azidobenzoic acid (1j) was obtained according to a
published method.14 Yield 1.57 g (65%). Colorless needles.
Mp 144°C (decomp.) (mp 144°C14). IR spectrum (oil
suspension), ν, cm–1: 2131, 2110, 2081 (νas N3), 1692 (ν
12-Oxo-6,12-dihydroazepino[2,1-b]quinazoline-6-carb-
oxylic acid ethyl ester (3c). Yield 3.4 mg (10%). Yellow
crystals. Mp 85°C (decomp.). H NMR spectrum, δ, ppm
1
C=O), 1267 (νs N3). H NMR spectrum, δ, ppm (J, Hz):
1
10.65 (1H, s, COOH); 8.11 (1H, dd, J = 7.9, J = 1.5, H Ar);
7.66–7.56 (1H, m, H Ar); 7.31–7.21 (2H, m, H Ar).
13C NMR spectrum, δ, ppm: 168.8 (C=O); 140.4, 134.6,
133.4, 125.1, 120.9, 119.7 (С Ar). Found, %: C 51.53;
H 3.07. C7H5N3O2. Calculated, %: C 51.54; H 3.09.
(J, Hz): 8.30 (1H, dd, J = 8.1, J = 1.0, H Ar), 7.75–7.69
(1H, m, H Ar); 7.66 (1H, d, J = 9.4, H azepine); 7.60 (1H, d,
J = 8.0, H Ar); 7.50–7.44 (1H, m, H Ar); 6.38–6.26 (3H, m,
H azepine); 4.39–4.28 (2H, m, OCH2); 4.44–4.39 (1H, m,
H azepine); 1.32 (3H, t, J = 7.1, CH3). 13C NMR spectrum, δ,
ppm: 168.3 (O–C=O); 160.8 (N–C=O); 151.9 (C–C=N);
147.6 (C=C–N); 134.6, 128.1, 127.2, 126.9, 126.5, 125.7,
120.4, 119.9 (C azepine); 61.8 (CH2); 51.8 (C azepine); 14.2
(CH3). Mass spectrum, m/z (Irel, %): 282 [M]+ (10), 236
[M–EtOH]+ (33), 210 (34), 209 [M–EtOC(O)]+ (100), 182
(11), 181 (14), 179 (8), 154 (11), 121 (11), 119 (9). Found,
%: C 67.87; H 5.12. C16H14N2O3. Calculated, %: C 68.07;
H 5.00.
Synthesis of 6-substituted 12-oxo-6,12-dihydroazepino-
[2,1-b]quinozalines 3a–d,f (General method). The
corresponding azide 1a–d,f (0.12 mmol) and sodium
2-azidobenzoate (1h) (58.7 mg, 0.37 mmol) were dissolved
in 1,4-dioxane–water 1:1 mixture (23 ml), and the solution
irradiated (2 × BUF-15, 254 nm, 7 mW/cm2) with vigorous
stirring (magnetic stirring) until complete decomposition of
the azide (3 h, monitoring by HPLC). The solvent was
removed under reduced pressure. The residue was
dissolved in water and acidified with 2% H3PO4. The
solution was stirred for about 3 min (compound 3a), 3 h
(compound 3с), and for 10 h (compounds 3b,d–f) at 5°С.
The obtained product was extracted with CCl4, the extract
washed with aqueous Na2CO3 followed by water, dried
over anhydrous Na2SO4, and purified by column
chromatography on silica gel with CCl4–CH2Cl2, 2:1, as
eluent.
12-Oxo-6,12-dihydroazepino[2,1-b]quinazoline-6-carb-
oxylic acid isopropyl ester (3d). Yield 2.8 mg (8%).
Yellow crystals. Mp 130–132°C. H NMR spectrum, δ,
1
ppm (J, Hz): 8.31–8.27 (1H, m, H Ar); 7.75–7.69 (1H, m,
H Ar); 7.65 (1H, d, J = 9.4, H azepine); 7.58 (1H, d,
J = 8.1, H Ar); 7.51–7.43 (1H, m, H Ar); 6.40 (1H, dd,
J = 9.5, J = 6.0, H azepine); 6.34 (1H, dd, J = 9.4, J = 4.8,
H azepine); 6.29–6.24 (1H, m, H azepine); 5.25 (1H, sept,
J = 6.3, OCH); 4.20–4.14 (1H, m, H azepine); 1.33 (3H, d,
J = 6.2, CH3); 1.28 (3H, d, J = 6.3, CH3). 13C NMR
spectrum, δ, ppm: 167.9 (O–C=O); 160.9 (N–C=O); 152.1
(C–C=N); 147.8 (C=C–N); 134.7, 128.4, 127.4, 127.3,
127.1 (С Ar); 126.6, 125.7, 120.6, 120.1 (С azepine); 69.6
(OCH); 51.7 (С azepine); 21.9; 21.8 (CH3). Mass spectrum,
m/z (Irel, %): 296 [M]+ (17), 236 [M–i-PrOH]+ (8), 211 (5),
210 (38), 209 [M–i-PrOC(O)]+ (100), 182 (7), 181 (9), 154
(6), 127 (5), 43 (7). Found, %: C 68.82; H 5.60. C17H16N2O3.
Calculated, %: C 68.91; H 5.44.
12-Oxo-6,12-dihydroazepino[2,1-b]quinazoline-6-carbo-
nitrile (3f). Yield 2 mg (7%). Yellow crystals. Mp 125°C
(decomp.). H NMR spectrum, δ, ppm (J, Hz): 8.99–8.95
(1H, m, H Ar); 8.43 (1H, d, J = 11.3, H Ar); 7.98–7.95 (1H,
m, H Ar); 7.94–7.87 (2H, m, H azepine); 7.80–7.68 (1H,
m, H Ar); 7.61–7.45 (2H, m, H azepine); 6.85 (1H, t, J = 7.1,
H azepine). 13C NMR spectrum, δ, ppm: 158.5 (N–C=O);
147.9 (C–C=N); 142.4 (C=C–N); 136.1; 135.2; 131.4;
128.1; 127.6 (С Ar); 127.0; 119.6; 116.8; 114.8; 110.6
12-Oxo-6,12-dihydroazepino[2,1-b]quinazoline-6-carb-
oxylic acid methyl ester (3a). Yield 9.6 mg (30%).
Yellow crystals. Mp 121–123°C (decomp.). 1H NMR
spectrum, δ, ppm (J, Hz): 8.32–8.26 (1H, m, H-1); 7.75–
7.69 (1H, m, H-3); 7.66 (1H, d, J = 9.4, H-10); 7.61 (1H, d,
J = 8.1, H-4); 7.47 (1H, t, J = 7.5, H-2); 6.43–6.37 (1H, m,
H-7); 6.37–6.31 (1H, m, H-9); 6.27 (1H, ddd, J = 9.5,
J = 4.7, J = 0.6, H-8); 4.28 (1H, d, J = 5.1, 6-CH); 3.85
(3H, s, CH3). 13C NMR spectrum, δ, ppm 168.9 (O–C=O);
160.8 (N–C=O); 152.0 (C-5a); 147.7 (C-4a); 134.7 (C-3);
128.0 (C-7); 127.5 (C-4); 127.4 (C-2); 127.2 (C-1); 126.7
(C-10); 126.0 (C-8); 120.5 (C-9); 120.1 (C-12a); 52.9
(OCH3); 51.9 (C-6). Mass spectrum, m/z (Irel, %): 268 [M]+
(21), 237 (19), 236 [M–CH3OH]+ (100), 210 (18), 209
[M–CH3OC(O)]+ (74), 208 (12), 182 (16), 181 (23), 180
(16), 179 (11). Found, %: C 66.82; H 4.80. C15H12N2O3.
Calculated, %: C 67.16; H 4.51.
1
8-Bromo-12-oxo-6,12-dihydroazepino[2,1-b]quinazo-
line-6-carboxylic acid methyl ester (3b). Yield 12.5 mg
698